Adverum Biotechnologies Inc
ADVM·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$3.57
Today
-18.3%
YTD
-18.4%
About
Operating within the US, Adverum Biotechnologies is a healthcare company founded in 2006 and headquartered in Emeryville, California. The firm is a clinical-stage gene therapy company engaged in developing gene therapy product candidates to treat ocular and rare diseases. Trading on the NASDAQ CM, the firm uses the ticker ACVM. Consider adding ACVM stock to diversify your eToro portfolio.
Price chart
Closing price history for ADVM (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-0.51
P/S (TTM)0.00
P/B (TTM)-1.72
Market cap$95.92M
Cap tierMicro-cap
Industry avg P/E-6.15
Profitability
Gross margin-191.80%
EBIT margin0.00%
Net margin-2713.40%
ROE-417.79%
ROA-120.47%
Earnings & Revenue
Revenue (TTM)$0.00
Revenue growth (1Y)-100.0%
EPS (TTM)-$8.57
Free cash flow$-138.44M
Total debt$88.94M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.86
Employees155
Next earnings31 Mar '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.